Medtronic Plc Income Statement Quarterly
MDT
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Jan 26 2018) III. Quarter |
(Oct 27 2017) II. Quarter |
(Jul 28 2017) I. Quarter |
(Apr 28 2017) IV. Quarter |
(Jan 27 2017) III. Quarter |
Revenue From Contract With Customer Excluding Assessed Tax |
- |
- |
- |
|
- |
Total Revenue |
7,369.00 |
7,050.00 |
7,390.00 |
7,916.00 |
7,283.00 |
Cost of Goods and Services Sold |
2,191.00 |
2,120.00 |
2,349.00 |
2,436.00 |
2,268.00 |
Gross
Profit |
5,178.00 |
4,930.00 |
5,041.00 |
5,480.00 |
5,015.00 |
Selling, Administration, Marketing |
2,499.00 |
2,438.00 |
2,485.00 |
2,479.00 |
2,388.00 |
Gain (Loss) on Disposition of Assets and Other Investments |
- |
-697.00 |
- |
- |
- |
Depriciation & Amortization |
461.00 |
460.00 |
454.00 |
516.00 |
497.00 |
Research and Development Expense (Excluding Acquired in Process Cost) |
558.00 |
555.00 |
548.00 |
553.00 |
530.00 |
Restructuring |
26.00 |
7.00 |
44.00 |
- |
- |
Other operatinig exp. /-income |
-87.00 |
111.00 |
66.00 |
783.00 |
46.00 |
Unusual Income/ -Expense |
- |
- |
- |
- |
- |
Special Charges Gains |
- |
80.00 |
- |
-100.00 |
100.00 |
Restructuring Charges Net of Restructuring Reversals |
7.00 |
8.00 |
8.00 |
-68.00 |
21.00 |
Loss Contingency Accrual Provision |
61.00 |
- |
- |
-218.00 |
218.00 |
Acquisition Related Gains Charges |
- |
- |
- |
-96.00 |
68.00 |
Disposition of Business Related Expenses |
- |
67.00 |
47.00 |
- |
- |
Other Than Temporary Impairment Losses Investments Availableforsale Securities |
227.00 |
- |
- |
- |
- |
Total operating costs including COS |
5,943.00 |
5,149.00 |
6,001.00 |
6,285.00 |
6,136.00 |
Operating income/-loss
|
1,426.00 |
1,901.00 |
1,389.00 |
1,631.00 |
1,147.00 |
Other Deductions / - Income |
Interest expense |
270.00 |
273.00 |
286.00 |
290.00 |
268.00 |
Interest income |
-98.00 |
-100.00 |
-92.00 |
-94.00 |
-88.00 |
Net interest expense/-income |
172.00 |
173.00 |
194.00 |
196.00 |
180.00 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Sale of Business |
- |
- |
- |
- |
- |
Sale of Assets |
- |
- |
- |
- |
- |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
227.00 |
- |
- |
- |
- |
Total costs & expenses |
6,342.00 |
5,322.00 |
6,195.00 |
6,481.00 |
6,316.00 |
Income /-loss before income taxes |
1,027.00 |
1,728.00 |
1,195.00 |
1,435.00 |
967.00 |
Income taxes expenses/-benefit |
2,419.00 |
-285.00 |
186.00 |
271.00 |
147.00 |
Income after income taxes |
-1,392.00 |
2,013.00 |
1,009.00 |
1,164.00 |
820.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-1,392.00 |
2,013.00 |
1,009.00 |
1,164.00 |
820.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-1,392.00 |
2,013.00 |
1,009.00 |
1,164.00 |
820.00 |
Noncontrolling interests |
3.00 |
4.00 |
7.00 |
9.00 |
-1.00 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-1,389.00 |
2,017.00 |
1,016.00 |
1,163.00 |
821.00 |
EBIT |
1,199.00 |
1,901.00 |
1,389.00 |
1,631.00 |
1,147.00 |
EBITD |
1,865.00 |
2,579.00 |
2,025.00 |
2,349.00 |
1,877.00 |
EBITDA |
1,868.00 |
2,579.00 |
2,015.00 |
2,349.00 |
1,884.00 |
Per
Share (GAAP Quarterly, in $) |
(Jan 26 2018) III. Quarter |
(Oct 27 2017) II. Quarter |
(Jul 28 2017) I. Quarter |
(Apr 28 2017) IV. Quarter |
(Jan 27 2017) III. Quarter |
Basic EPS (excl. extra
items) |
-1.03 |
1.49 |
0.75 |
0.85 |
0.60 |
Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
-1.03 |
1.49 |
0.75 |
0.85 |
0.60 |
Basic shares outstanding (Mill.
of Units) |
1,354.00 |
1,355.10 |
1,361.90 |
1,371.20 |
1,372.20 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
-1.03 |
1.48 |
0.74 |
0.84 |
0.59 |
Diluted average shares (Mill.
of Units) |
1,354.00 |
1,365.80 |
1,375.60 |
1,382.90 |
1,383.10 |
Dividend per share |
0.46 |
0.46 |
0.46 |
0.43 |
0.43 |
|
|